Effects of antibiotics on synthesis and persistence of sigma E in sporulating Bacillus subtilis.
A potential regulatory link between the activation of a sporulation-specific sigma factor (sigma E) and forespore septum formation was investigated by treating Bacillus subtilis with inhibitors of protein or peptidoglycan synthesis and monitoring the consequences of these treatments on sigma E activation and septation. Western blot (immunoblot) and electron microscopic analyses revealed that both the formation of sigma E and septation were inhibited to a similar degree when either rifampin or chloramphenicol was added at different times before the second hour into sporulation but that penicillin preferentially blocked septation. We interpret these results as indicating that the syntheses of the gene products for both septation and sigma E activation occur at approximately the same time in development but that synthesis of an intact septum is unlikely to be a prerequisite for the formation of sigma E. We observed that penicillin could not only block septation but, depending on the time of its addition, could also inhibit both the activation of sigma E and the synthesis of its precursor. The basis of this effect is unknown, but it is not due to an overall disruption of protein synthesis. The incorporation of [35S] methionine by the sporulating cultures was unaffected by penicillin treatment. A time course study of the effects of rifampin and chloramphenicol treatments on sigma E levels revealed that both the synthesis of sigma E and its disappearance from sporulating cultures is inhibited by these antibiotics. This suggests that ongoing macromolecular synthesis is required for the turnover of sigma E.
Jonas
R M
RM
Department of Microbiology, University of Texas Health Science Center, San Antonio 78284-7758.
Holt
S C
SC
Haldenwang
W G
WG
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D001426:Bacterial Proteins / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism*; D002701:Chloramphenicol / Q000494:pharmacology; D007700:Kinetics; D008854:Microscopy, Electron; D010400:Penicillin G / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D012808:Sigma Factor; D013171:Spores, Bacterial / Q000502:physiology / Q000648:ultrastructure; D014157:Transcription Factors
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D012808:Sigma Factor; D014157:Transcription Factors; C063202:sporulation-specific sigma factors; D002701:Chloramphenicol; D010400:Penicillin G; D012293:Rifampin